STRUCTURE AND EXPRESSION OF EUCARYOTIC GENES

Information

  • Research Project
  • 3293597
  • ApplicationId
    3293597
  • Core Project Number
    R01GM037823
  • Full Project Number
    5R01GM037823-03
  • Serial Number
    37823
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/1986 - 38 years ago
  • Project End Date
    3/31/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    4/1/1989 - 35 years ago
  • Budget End Date
    3/31/1990 - 34 years ago
  • Fiscal Year
    1989
  • Support Year
    3
  • Suffix
  • Award Notice Date
    3/15/1989 - 35 years ago
Organizations

STRUCTURE AND EXPRESSION OF EUCARYOTIC GENES

We propose to continue our studies on the structure and expression of the actin genes of the nematode Caenorhabditis elegans. We will now focus on actin messenger RNA (mRNA) processing and extend the work to include processing of other mRNAs. While studying the actin genes, we recently discovered that three of the four genes encode mRNAs that undergo an unusual reaction in which the 5' 22 nucleotides of the mRNAs are derived from a separate RNA molecule. Other mRNAs in C. elegans also undergo this trans-splicing reaction. We will study this phenomenon and its biological implications. We will elucidate the mechanism of trans-splicing of the actin mRNAs in C. elegans. We will characterize the actin mRNA precursors, the splice leader RNA precursor, and molecular intermediates. We will use in vitro splicing reactions to identify the components of the reaction, determine if separate trans-and cis- elements (snRNPs and spliceosomes) exist and cis-splicing is kept separate from trans-splicing we will identify other MRNAs that undergo the same transplicing reaction. We will investigate whether the splice leader confers mRNA stability, enhances translation, or localizes mRNAs. We will carry out experiments to determine whether similar splice leaders are acquired through trans-splicing in other eukaryotes.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    862
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    MBY
  • Study Section Name
    Molecular Biology Study Section
  • Organization Name
    SYNERGEN, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BOULDER
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    80301
  • Organization District
    UNITED STATES